Bank Julius Baer & Co
VIR icon

Bank Julius Baer & Co’s Vir Biotechnology VIR Stock Holding History

Bank Julius Baer & Co’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,389
Closed -$336K – 569
2023
Q4 		$336K Sell
33,389
-9
-0% -$82 ﹤0.01% 358
2023
Q3 		$313K Buy
33,398
+656
+2% +$9.36K ﹤0.01% 357
2023
Q2 		$803K Sell
32,742
-3,904
-11% -$98K ﹤0.01% 287
2023
Q1 		$853K Buy
36,646
+2,543
+7% +$65K 0.01% 284
2022
Q4 		$863K Buy
34,103
+2,223
+7% +$54.5K 0.01% 283
2022
Q3 		$615K Sell
31,880
-65,007
-67% -$1.65M ﹤0.01% 315
2022
Q2 		$2.47M Sell
96,887
-19,863
-17% -$464K 0.02% 197
2022
Q1 		$3M Sell
116,750
-18,779
-14% -$557K 0.02% 197
2021
Q4 		$5.67M Sell
135,529
-298,627
-69% -$11.7M 0.03% 191
2021
Q3 		$18.9M Buy
434,156
+98,644
+29% +$4.27M 0.12% 118
2021
Q2 		$15.9M Buy
335,512
+83,516
+33% +$3.8M 0.1% 143
2021
Q1 		$12.9M Buy
251,996
+105,245
+72% +$5.67M 0.1% 141
2020
Q4 		$3.93M Buy
146,751
+117,945
+409% +$3.83M 0.03% 208
2020
Q3 		$989K Buy
+28,806
New +$1.24M 0.01% 296

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank Julius Baer & Co's VIR Position: Q1 2024 in Review

Bank Julius Baer & Co sold out of Vir Biotechnology (VIR) in Q1 2024, closing a stake of 33,389 shares — an estimated $336K sold.

Bank Julius Baer & Co first reported a position in VIR in Q3 2020 and held it in 14 quarters. The position peaked at $18.9M in Q3 2021. 209 funds tracked by Wall St. Rank hold VIR as of Q1 2024.

  • Bank Julius Baer & Co reported no remaining Vir Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Bank Julius Baer & Co sold 33,389 Vir Biotechnology shares in Q1 2024, an estimated $336K.
  • Bank Julius Baer & Co first reported a position in Vir Biotechnology in Q3 2020 and held it in 14 quarters.
  • Bank Julius Baer & Co's Vir Biotechnology position peaked at $18.9M in Q3 2021.
  • 209 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2024.

Based on Bank Julius Baer & Co's 13F filing for Q1 2024, filed 14 May 2024.